Below is an overview of the ECC 2013 Young Oncologists Track sessions to which you do not need to be registered but has free access to congress attendees.
Young Oncologist Committee member Evando De Azambuja recommends you attend the special session in the Young Oncologist Track, ‘How to be a Happy Oncologist’ to take part in the discussion on how to handle burn-out and ensure a good life-job balance
Special Session: How to be a Happy Oncologist
Sunday 29 September 2013, 13:15 - 14:15
Chair: E. De Azambuja (Belgium)
- Quality of life of young oncologists, P. Blanchard (France)
- Why choose oncology? How to identify goals/aims/barriers towards professional fulfilment for young oncologists, P. Dubsky (Austria)
- Managing burnout in oncology – special focus on young oncologists, L. Fallowfield (United Kingdom)
- Discussion and Roundup
Roundtable: How to Improve Career Opportunities for Young Oncologists across Europe
Sunday 29 September 2013, 17:00 - 18:00
Moderator: F. Cardoso (Portugal)
Young Oncologists Speakers:
- Greece - D. Zardavas (Belgium)
- Italy - I. Meattini (Italy)
- Spain - E. Castro (United Kingdom)
- The Netherlands - S. Sleijfer (The Netherlands)
Discussion with Panel of Experts
Panellists: J. Bergh (Sweden), R. Audisio (United Kingdom), M. Mangoni (Italy)
Special Session: Improving Hands-on Education for Young Oncologists
Monday 30 September 2013, 13:15 - 14:15
Chair: P. Blanchard (France)
- Training surgical oncologists in Europe, P. Naredi (Sweden)
- Training medical oncologists in Europe, J.F. Smyth (United Kingdom)
- Training radiation oncologists in Europe, R. Pötter (Austria)
- Discussion and Roundup
Scientific Symposium: Integrating Genetic Information into Daily Clinical Practice
Monday 30 September 2013, 14:45 - 16:45
Chairs: S. Loibl (Germany), S. Banerjee (United Kingdom)
- Introduction, S. Loibl (Germany)
- Germline mutations and cancer susceptibility, N. Rahman (United Kingdom)
- Expression profiling in breast cancer: ready for clinical use?, C. Sotiriou (Belgium)
- Genetic analysis in advanced cancer patients: what test for which patient? Matching patient, biomarker and drug, J. Rodon (Spain)
- Impact of genetic analyses on patients - what to tell our patients?, M. Abramowicz (Belgium)
- Concluding Remarks, S. Banerjee (United Kingdom)